Mansueto invests in University of Chicago food-allergy startup

A startup led by a top University of Chicago researcher has landed $3.5 million in seed funding from investors who include Morningstar founder Joe Mansueto. ClostraBio is developing a treatment for food allergies that involves bacteria developed in a lab that prevent allergic reactions. The company …
Read more: Mansueto invests in University of Chicago food-allergy startup

Leave a Reply

Your email address will not be published. Required fields are marked *